Archive Newsletter
-
05.11.26 -- Vaccine Platform Vs. CDMO Model: Outsourcing Lessons For All Biopharma
5/11/2026
05/11/26 Cell & Gene Newsletter
-
05.09.26 -- Cell & Gene Best Of April
5/9/2026
05/09/26 Cell & Gene Newsletter
-
05.08.26 -- Insights And Support For Clinical Trial Optimization
5/8/2026
05/08/26 Cell & Gene Newsletter
-
05.08.26 -- How AI Could Clear Logistics Roadblocks Limiting Patient Access To CGT
5/8/2026
05/08/26 Cell & Gene Newsletter
-
05.07.26 -- Lilly's Unified Mindset For A Global Parenteral And Device Manufacturing Network
5/7/2026
05/07/26 Cell & Gene Newsletter
-
05.06.26 -- Regulatory Flexibility In CGT: Key Shifts & Implications With Monika Swietlicka
5/6/2026
05/06/26 Cell & Gene Newsletter
-
05.05.26 -- Enhance CAR T Quality With Optimized Automation And Functional Analysis
5/5/2026
05/05/26 Cell & Gene Newsletter
-
05.05.26 -- STREAM Edition: Advancing Early Detection In Rare Cancers With Catriona Jamieson, M.D., Ph.D.
5/5/2026
05/05/26 Cell & Gene Newsletter
-
05.05.26 -- Mapping Candel Therapeutics' Sprint To The BLA Finish Line
5/5/2026
05/05/26 Cell & Gene Newsletter
-
05.04.26 -- Cell And Gene Therapy CDMOs: On The Path To $75 Billion In Services?
5/4/2026
05/04/26 Cell & Gene Newsletter